QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 13, 2023 at 09:01 pm
Share
QHSLab, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.336407 million compared to USD 0.269323 million a year ago. Net loss was USD 0.082443 million compared to USD 0.310115 million a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago. Diluted earnings per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago.
For the nine months, sales was USD 1.09 million compared to USD 0.975469 million a year ago. Net loss was USD 0.381725 million compared to USD 0.779804 million a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.09 a year ago. Diluted earnings per share from continuing operations was USD 0.04 compared to USD 0.09 a year ago.
QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company. The Company focuses on enabling primary care physicians (PCPs) to increase their revenues by providing them with tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. The products that the Company provides its physician clients enables them to diagnose and treat patients with chronic diseases The Company is engaged in providing PCPs with the software, training and devices necessary that allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine. Its digital healthcare, clinical decision support and point of care solutions also support non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and are reimbursable to medical practice.